TIME TO ACCESS ORPHAN MEDICINES IN GREECE

被引:0
|
作者
Chantzaras, A. [1 ]
Margetis, A. [1 ]
Kani, C. [1 ]
Koutsiouris, V [2 ]
Bacopoulou, F. [1 ]
机构
[1] Hlth Technol Assessment & Reimbursement Comm, Athens, Greece
[2] Hellen Minist Hlth, Athens, Greece
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA173
引用
收藏
页码:S352 / S352
页数:1
相关论文
共 50 条
  • [1] PATIENT ACCESS TO ORPHAN MEDICINES IN TURKEY
    Kockaya, G.
    Ergin, Oguzhan G.
    Kurnaz, M.
    Okcun, S.
    Talay, D.
    Gedik, Sar C.
    Saylan, M.
    VALUE IN HEALTH, 2019, 22 : S854 - S855
  • [2] Analysis of the evolution in the access to orphan medicines in Spain
    Mestre-Ferrandiz, Jorge
    Iniesta, Margarita
    Trapero-Bertran, Marta
    Espin, Jaime
    Brosa, Max
    GACETA SANITARIA, 2020, 34 (02) : 141 - 149
  • [3] TIME TO MARKET ACCESS FOR ONCOLOGY MEDICINES IN GREECE: HAS IT CHANGED DURING THE CRISIS?
    Filosofou, S.
    Naoum, P.
    Kyriopoulos, D.
    Athanasakis, K.
    Theodorou, M.
    VALUE IN HEALTH, 2017, 20 (09) : A460 - A460
  • [4] ACCESS TO ORPHAN DRUGS IN GREECE DURING ECONOMIC CRISIS
    Tsiantou, V
    Mylona, K.
    Karampli, E.
    Boubouchairopoulou, N.
    Kyriopoulos, I. I.
    Athanasakis, K.
    Gabriel, E.
    Makridaki, D.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2014, 17 (07) : A541 - A541
  • [5] UNMET NEED, STRENGTH OF EVIDENCE, AND PRICE: IMPACT ON TIME TO ACCESS FOR ORPHAN MEDICINES IN ENGLAND AND FRANCE
    Fernandes, J.
    Kumar, A.
    Cassidy, C.
    VALUE IN HEALTH, 2020, 23 : S704 - S704
  • [6] Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
    Merlini, Giampaolo
    Gribben, John
    Macintyre, Elizabeth
    Piggin, Maria
    Doeswijk, Robin
    HEMASPHERE, 2020, 4 (05):
  • [7] INTERNATIONAL COOPERATION AS A PREREQUISITE FOR IMPROVEMENT OF ACCESS TO ORPHAN BIOLOGIC MEDICINES
    Wieckowski, Zbigniew
    MEDICINE LAW & SOCIETY, 2021, 14 (02): : 479 - 493
  • [8] A CROSS-COUNTRY COMPARISON OF REIMBURSED ORPHAN MEDICINES IN BULGARIA, GREECE AND ROMANIA
    Kamusheva, Maria
    Stoimenova, Assena
    Doneva, Miglena
    Zlatareva, Albena
    Petrova, Guenka
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2013, 27 (05) : 4186 - 4192
  • [9] Market access for medicines treating rare diseases: Association between specialised processes for orphan medicines and funding recommendations
    Fontrier, Anna-Maria
    SOCIAL SCIENCE & MEDICINE, 2022, 306
  • [10] Clinical trials of orphan medicines
    Buckley, Brendan M.
    LANCET, 2008, 371 (9629): : 2051 - 2055